Member Info for dan1nat1

Around 5 minutes after the funding is secured RNS I reckon ;)

Q2 next week, hopefully an interesting few months ahead, as soon as the finance is in place we should really see some movement!

I agree that’s why I think they must be confident.

I to think this update was buried, in fact I only had chance to skim read it first thing this morning and totally missed the update at the bottom until I got chance to do a full read through.

Could it also be they are confident of the Yoda outcome and want to save time later?

What’s changed could be the new sub group discovered Q4 last year?

Mani,

Agreed we probably do not have the full picture yet, I hope we get an interview soon and some clarity can be brought to the market.

For a small quick raise like this one, I don’t know why they just didn’t do the book build and advise when it was complete?

I wont complain about the small rise, but maybe they expected more?

Going off the last interview I think they had expected to have a partnership in place before now, hopefully this small raise will give us enough time to get at least one in place before any other form of funding is required.

With further data due over the next few months, we should be well placed for that to happen.

Do you think 3 is someones lucky number ;)

Pred the book is probably already closed, and placing price from the RNS is -

"The Fund raise is expected to be conducted at or around the prevailing market price"

So I am hopefully we wont see any drop from here, and can secure a partner deal before to long.

"The design and preparation of a new Phase III study, called CALIBER, based on INTEREST data post hoc analysis"

If the markets / potential partners can be convinced of the COS on Caliber based on the data from the last trial we really could be ready to re-rate!

The book is due to close latest 11.30 this morning, so let’s hope not to many pi’s shit the bed before then.

I expect further news very soon -

“Further Traumakine development through the design and preparation of a global Phase III clinical trial, CALIBER”

This has not been mentioned before, and is probably related to the results from Yoda.

Looks like some need to say something to Mani?

Fingers crossed for a 7am ‘Recommened cash offer’ RNS then.

I’ll be happy with anything over £1.50, though £2 would be 33% better ;)

I was agreeing with you Mani.

I know you didn’t post it to ramp, but it really is quite the opposite of a deramp. I suppose it’s hard to convey a tongue in cheek comment on here.

Haha,

I thought the same thing mani, your comment about a takeover almost rivals Zen’s ramps today...almost ;)

Nice little flurry fro just before 3pm.

Have the rumours starts in the States?

Has got a lot more interest than normal today, could be the long awaited news is about to drop?

If we do get approached, I would like to think it would be £1.50+

Our usable tax losses alone are worth our current market cap, assuming they are usable by any potential suitor.